Heart failure is caused by the heart being unable to maintain normal blood flow. Some patients with heart failure expressed that they needed nurses' help with their physical, psychological, and spiritual problems. Spiritual Well-Being and its components play an important role in a person's declining quality of life and have been linked to various other health factors. This research aims to determine the relationship between spiritual well-being and the quality of life of heart failure patients. The sample for this research was 100 respondents taken using the accidental sampling technique. Data analysis uses the chi-square correlation test if the test conditions are met. If the test requirements are not met, use the alternative Fisher exact test. The instruments used in this research were the Spiritual Needs Questionnaire (SpNQ) and the Minnesota Living with Heart Failure Questionnaire (MLHFQ). The results of this study illustrate that there is no relationship between quality of life scores and all aspects of the spiritual needs of heart failure patients (p> 0.05). The results of the analysis carried out showed that NYHA functional status (p= 0.044) and ejection fraction (r= -0.205, p= 0.041) influenced the spiritual needs of heart failure patients. The results of this study indicate that the patient's spiritual needs are not related to the general quality of life score, but have a significant relationship with the physiological dimensions of quality of life, ejection fraction, and NYHA functional status.
20 May 2025 in Health Leadership and Quality of Life
Agoraphobia with panic disorder (PD) is a phobia-anxiety condition that makes sufferers avoid situations or locations where it could feel embarrassed or be unable to leave or get help in case of a PD. Agoraphobia has been associated with recurrent PD syndrome over the last 50 years, and in many instances, it is regarded to represent the normal progression or complication of PD. Even though agoraphobia with PD is quite common in patients receiving primary care, medical professionals often fail to recognize and adequately treat the disease. These medications alleviate the usually associated depression symptoms as well. Selective Serotonin Reuptake Inhibitor (SSRI) are well-tolerated and effective for both anxious and depressive symptoms, making the primary option for treating agoraphobia with PD in the short, medium, and long term. SSRIs which are less likely to cause withdrawal symptoms after abrupt discontinuation should be used for long-term prophylaxis. Tricyclic Antidepressant (TCA) can be a second-line therapy for PD if SSRIs don't work, although venlafaxine hasn't been researched long-term. High-potency medications are advantageous choices for short-term therapy since ithas been shown to have a quick start of anti-anxiety action, having favorable benefits. Cognitive-Behavioral Therapy (CBT), which is the non-pharmacological approach that has gotten the most research, can be employed with a variety of patients depending on how easily it is accessible.
Opioids strongly modulate numerous physiological and psychological functions. They may induce euphoria and analgesia, which cultures have sought for generations when administered abruptly. Chronic opioid usage alters neural circuitry and creates a drug-dependent condition. During drug withdrawal, allostatic alterations caused by drug dependence are evident. Drug use stops a temporary coordinated allostatic re-established of neural circuits, which manifest as physiology and psychological consequences that are the opposite of those seen throughout sensitive drug intoxicates. Physical withdrawal symptoms, for example, go away in a matter of days, although other symptoms, such as dysphoria, sleeplessness, and anxiety, might last. Some adaptations, like gathered connections, can become permanent. The brain circuitry, cellular processes, and opioids drug dependence suggest a potential role for neuroinflammation. The taught association involving opioids and alleviation from a preexisting or withdrawal-induced anxiogenic and dysphoric state leads to opioids-addicted behaviors. Drug cravings among susceptible persons living in an increasingly pressured environment would be fueled by a taught link between drug use and respite from unpleasant moods. We contend that the present opioids crisis in the USA is exacerbated by this path to addiction.
One of the most difficult conditions to treat while dealing with post-stroke aphasia and depression is related. To help stroke survivors manage their depression symptoms, stroke medical professionals are essential. In light of stroke specialists' opinions about post-stroke aphasia, this study intends to investigate current methods of treating depression. In five semi-structured focus groups, thirty-nine stroke healthcare professionals from various phases of stroke therapy took part. A thorough transcript analysis of these focus group talks was conducted using the interpretive description approach. After the transcripts were analyzed, several themes emerged, including the difficulties associated with treating depression and aphasia at the same time in stroke rehabilitation, the undervaluing of mood disorders in clinical practice, the use of ad hoc methods for diagnosis and treatment, and the attempts of stroke doctors to fill in the gaps in psychological care. This study emphasizes how difficult it is for doctors to treat depression in patients who have had a stroke-related aphasia. For better patient care, evidence-based therapies are crucial, as is the inclusion of mental health services in stroke rehabilitation. Policies that promote mental health should be developed, leaders should take the lead in putting comprehensive treatment plans into practice, and healthcare professionals should get specialized training. These initiatives have a critical role in enhancing the results and standard of life for those coping with the co-occurring conditions of depression and aphasia after stroke.